Kinetic patterns of liver enzyme elevation with COVID-19 in the USA
- PMID: 32501877
- PMCID: PMC7299115
- DOI: 10.1097/MEG.0000000000001792
Kinetic patterns of liver enzyme elevation with COVID-19 in the USA
Abstract
COVID-19 is a global pandemic that started in Wuhan, China. COVID-19 related liver enzyme elevations have been described however the clinical presentation, enzyme kinetics, and associated laboratory abnormalities of these patients have not been well described. Five cases of COVID-19 associated liver enzyme elevations are reported here. We found that COVID-19 related liver enzyme elevations occurred in a hepatocellular pattern and persisted throughout the initial hospitalization in all patients. Abnormalities in lactate dehydrogenase and ferritin levels were seen in all five cases. In conclusion, abnormalities in aminotransferase, lactate dehydrogenase, and ferritin levels are commonly seen in COVID-19 related liver injury. Elevated aminotransferase levels often persist throughout the entire hospitalization. However, the clinical course of COVID-19 related liver injury appears benign.
Conflict of interest statement
D.D.: Participates on the advisory board and received research grants from Gilead and Abbvie. For the remaining authors, there are no conflicts of interest.
Figures
References
-
- Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA, et al. <em>Severe acute respiratory syndrome-related coronavirus</em>: the species and its viruses – a statement of the Coronavirus Study Group. bioRxiv. 2020:2020.2002.2007.937862
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323:1239–1242 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
